Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease
Background— In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basall...
Saved in:
| Published in | Circulation (New York, N.Y.) Vol. 115; no. 12; pp. 1551 - 1562 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hagerstown, MD
Lippincott Williams & Wilkins
27.03.2007
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background—
In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basally activated state, which suggests that pathological platelet activation may contribute to sickle cell disease vasculopathy.
Methods and Results—
Studies were therefore undertaken to examine transcriptional signaling pathways in platelets that may be dysregulated in sickle cell disease. We demonstrate and validate in the present study the feasibility of comparative platelet transcriptome studies on clinical samples from single donors by the application of RNA amplification followed by microarray-based analysis of 54 000 probe sets. Data mining an existing microarray database, we identified 220 highly abundant genes in platelets and a subset of 72 relatively platelet-specific genes, defined by >10-fold increased expression compared with the median of other cell types in the database with amplified transcripts. The highly abundant platelet transcripts found in the present study included 82% or 70% of platelet-abundant genes identified in 2 previous gene expression studies on nonamplified mRNA from pooled or apheresis samples, respectively. On comparing the platelet gene expression profiles in 18 patients with sickle cell disease in steady state to those of 12 black control subjects, at a 3-fold cutoff and 5% false-discovery rate, we identified ≈100 differentially expressed genes, including multiple genes involved in arginine metabolism and redox homeostasis. Further characterization of these pathways with real-time polymerase chain reaction and biochemical assays revealed increased arginase II expression and activity and decreased platelet polyamine levels.
Conclusions—
The present studies suggest a potential pathogenic role for platelet arginase and altered arginine and polyamine metabolism in sickle cell disease and provide a novel framework for the study of disease-specific platelet biology. |
|---|---|
| AbstractList | In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basally activated state, which suggests that pathological platelet activation may contribute to sickle cell disease vasculopathy.
Studies were therefore undertaken to examine transcriptional signaling pathways in platelets that may be dysregulated in sickle cell disease. We demonstrate and validate in the present study the feasibility of comparative platelet transcriptome studies on clinical samples from single donors by the application of RNA amplification followed by microarray-based analysis of 54,000 probe sets. Data mining an existing microarray database, we identified 220 highly abundant genes in platelets and a subset of 72 relatively platelet-specific genes, defined by >10-fold increased expression compared with the median of other cell types in the database with amplified transcripts. The highly abundant platelet transcripts found in the present study included 82% or 70% of platelet-abundant genes identified in 2 previous gene expression studies on nonamplified mRNA from pooled or apheresis samples, respectively. On comparing the platelet gene expression profiles in 18 patients with sickle cell disease in steady state to those of 12 black control subjects, at a 3-fold cutoff and 5% false-discovery rate, we identified approximately 100 differentially expressed genes, including multiple genes involved in arginine metabolism and redox homeostasis. Further characterization of these pathways with real-time polymerase chain reaction and biochemical assays revealed increased arginase II expression and activity and decreased platelet polyamine levels.
The present studies suggest a potential pathogenic role for platelet arginase and altered arginine and polyamine metabolism in sickle cell disease and provide a novel framework for the study of disease-specific platelet biology. Background— In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basally activated state, which suggests that pathological platelet activation may contribute to sickle cell disease vasculopathy. Methods and Results— Studies were therefore undertaken to examine transcriptional signaling pathways in platelets that may be dysregulated in sickle cell disease. We demonstrate and validate in the present study the feasibility of comparative platelet transcriptome studies on clinical samples from single donors by the application of RNA amplification followed by microarray-based analysis of 54 000 probe sets. Data mining an existing microarray database, we identified 220 highly abundant genes in platelets and a subset of 72 relatively platelet-specific genes, defined by >10-fold increased expression compared with the median of other cell types in the database with amplified transcripts. The highly abundant platelet transcripts found in the present study included 82% or 70% of platelet-abundant genes identified in 2 previous gene expression studies on nonamplified mRNA from pooled or apheresis samples, respectively. On comparing the platelet gene expression profiles in 18 patients with sickle cell disease in steady state to those of 12 black control subjects, at a 3-fold cutoff and 5% false-discovery rate, we identified ≈100 differentially expressed genes, including multiple genes involved in arginine metabolism and redox homeostasis. Further characterization of these pathways with real-time polymerase chain reaction and biochemical assays revealed increased arginase II expression and activity and decreased platelet polyamine levels. Conclusions— The present studies suggest a potential pathogenic role for platelet arginase and altered arginine and polyamine metabolism in sickle cell disease and provide a novel framework for the study of disease-specific platelet biology. In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basally activated state, which suggests that pathological platelet activation may contribute to sickle cell disease vasculopathy.BACKGROUNDIn sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced nitric oxide and arginine bioavailability. Recent functional studies of platelets in patients with sickle cell disease reveal a basally activated state, which suggests that pathological platelet activation may contribute to sickle cell disease vasculopathy.Studies were therefore undertaken to examine transcriptional signaling pathways in platelets that may be dysregulated in sickle cell disease. We demonstrate and validate in the present study the feasibility of comparative platelet transcriptome studies on clinical samples from single donors by the application of RNA amplification followed by microarray-based analysis of 54,000 probe sets. Data mining an existing microarray database, we identified 220 highly abundant genes in platelets and a subset of 72 relatively platelet-specific genes, defined by >10-fold increased expression compared with the median of other cell types in the database with amplified transcripts. The highly abundant platelet transcripts found in the present study included 82% or 70% of platelet-abundant genes identified in 2 previous gene expression studies on nonamplified mRNA from pooled or apheresis samples, respectively. On comparing the platelet gene expression profiles in 18 patients with sickle cell disease in steady state to those of 12 black control subjects, at a 3-fold cutoff and 5% false-discovery rate, we identified approximately 100 differentially expressed genes, including multiple genes involved in arginine metabolism and redox homeostasis. Further characterization of these pathways with real-time polymerase chain reaction and biochemical assays revealed increased arginase II expression and activity and decreased platelet polyamine levels.METHODS AND RESULTSStudies were therefore undertaken to examine transcriptional signaling pathways in platelets that may be dysregulated in sickle cell disease. We demonstrate and validate in the present study the feasibility of comparative platelet transcriptome studies on clinical samples from single donors by the application of RNA amplification followed by microarray-based analysis of 54,000 probe sets. Data mining an existing microarray database, we identified 220 highly abundant genes in platelets and a subset of 72 relatively platelet-specific genes, defined by >10-fold increased expression compared with the median of other cell types in the database with amplified transcripts. The highly abundant platelet transcripts found in the present study included 82% or 70% of platelet-abundant genes identified in 2 previous gene expression studies on nonamplified mRNA from pooled or apheresis samples, respectively. On comparing the platelet gene expression profiles in 18 patients with sickle cell disease in steady state to those of 12 black control subjects, at a 3-fold cutoff and 5% false-discovery rate, we identified approximately 100 differentially expressed genes, including multiple genes involved in arginine metabolism and redox homeostasis. Further characterization of these pathways with real-time polymerase chain reaction and biochemical assays revealed increased arginase II expression and activity and decreased platelet polyamine levels.The present studies suggest a potential pathogenic role for platelet arginase and altered arginine and polyamine metabolism in sickle cell disease and provide a novel framework for the study of disease-specific platelet biology.CONCLUSIONSThe present studies suggest a potential pathogenic role for platelet arginase and altered arginine and polyamine metabolism in sickle cell disease and provide a novel framework for the study of disease-specific platelet biology. |
| Author | Barb, Jennifer Morris, Sidney M. Munson, Peter J. Danner, Robert L. Solomon, Michael A. Kato, Gregory Villagra, Jose Suffredini, Anthony F. Xu, Xiuli Gladwin, Mark T. Raghavachari, Nalini Harris, Amy Logun, Carolea |
| Author_xml | – sequence: 1 givenname: Nalini surname: Raghavachari fullname: Raghavachari, Nalini organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 2 givenname: Xiuli surname: Xu fullname: Xu, Xiuli organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 3 givenname: Amy surname: Harris fullname: Harris, Amy organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 4 givenname: Jose surname: Villagra fullname: Villagra, Jose organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 5 givenname: Carolea surname: Logun fullname: Logun, Carolea organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 6 givenname: Jennifer surname: Barb fullname: Barb, Jennifer organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 7 givenname: Michael A. surname: Solomon fullname: Solomon, Michael A. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 8 givenname: Anthony F. surname: Suffredini fullname: Suffredini, Anthony F. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 9 givenname: Robert L. surname: Danner fullname: Danner, Robert L. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 10 givenname: Gregory surname: Kato fullname: Kato, Gregory organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 11 givenname: Peter J. surname: Munson fullname: Munson, Peter J. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 12 givenname: Sidney M. surname: Morris fullname: Morris, Sidney M. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information – sequence: 13 givenname: Mark T. surname: Gladwin fullname: Gladwin, Mark T. organization: From the Vascular Medicine Branch (N.R., X.X., J.V., G.K., M.T.G.), Cardiovascular Branch (M.A.S.), and NHLBI Genomics Core Facility (N.R., X.X., M.T.G.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; Functional Genomics and Proteomics Facility, Critical Care Medicine Department, Clinical Center (N.R., X.X., A.H., J.V., C.L., M.A.S., A.F.S., R.L.D., G.K., M.T.G.) and Mathematical and Statistical Computing Lab, Division of Bioscience, Center for Information |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18642324$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17353439$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1y0zAQxzVMGZoWXoERB7g5WJItWxcYjyk0M4FmSjocPYq8SgSyFCSn0HfgoVFJoJQTJ0m7v_2v9uMEHTnvAKFnJJ8SwsnLdnbZXs2b5eziQ3PeTEnOp7yseUEeoAkpaZEVJRNHaJLnucgqRukxOonxc3pyVpWP0DGpWMkKJiboRzNsrdEGenz2fRsgRuMdXgSvjTVujb3GCytHsDDiZZAuqmC2ox8AX8I1SBtxu5FuDREbh5uwNs44wO9hlCtvjcILOW6-yZtf7nQ34MaIP5lxgz8a9cUCbsFa_MZEkBEeo4c6ScKTw3mKrt6eLdvzbH7xbtY280wVohiz1IJS5IoWuq5XFWVQEdZzLelKlJrUHGTRM641LyURrOZ9pSTVXBEmiCK9YKfo1V53u1sN0Kv0qSBttw1mkOGm89J09z3ObLq1v-4opaWoqyTw4iAQ_NcdxLEbTFSpEunA72JX5SwvqOAJfPp3pj8pfg8gAc8PgIxKWp1arEy849JUKaNF4sSeU8HHGEDfIXl3uxTd_aVIZt7tlyLFvv4nVpkxzcLfFmfsfyj8BE6KwpY |
| CODEN | CIRCAZ |
| CitedBy_id | crossref_primary_10_1111_j_1538_7836_2011_04204_x crossref_primary_10_1152_ajprenal_00321_2022 crossref_primary_10_3109_09537104_2015_1083543 crossref_primary_10_1002_ajh_21475 crossref_primary_10_1007_s00281_011_0286_4 crossref_primary_10_1016_j_ccell_2015_09_018 crossref_primary_10_1182_blood_2010_12_324517 crossref_primary_10_2217_14796678_3_4_391 crossref_primary_10_1097_CCM_0b013e318186a720 crossref_primary_10_3389_fphys_2015_00054 crossref_primary_10_1038_s41598_020_64431_4 crossref_primary_10_1111_jth_12965 crossref_primary_10_3390_ijms23094973 crossref_primary_10_1016_j_bcmd_2008_01_008 crossref_primary_10_1016_j_jad_2012_02_008 crossref_primary_10_1016_S2352_3026_18_30020_6 crossref_primary_10_1182_blood_2009_10_246405 crossref_primary_10_1515_biol_2017_0049 crossref_primary_10_1111_j_1538_7836_2011_04208_x crossref_primary_10_1096_fj_201902142R crossref_primary_10_1186_s13059_016_1142_6 crossref_primary_10_1016_j_jacbts_2017_10_005 crossref_primary_10_3389_fphar_2018_00683 crossref_primary_10_1182_blood_2011_06_359802 crossref_primary_10_4081_btvb_2022_33 crossref_primary_10_2310_JIM_0b013e31820bf475 crossref_primary_10_1007_s10555_017_9674_0 crossref_primary_10_1080_09537104_2018_1562170 crossref_primary_10_1080_09537100801947434 crossref_primary_10_1016_j_jprot_2014_02_008 crossref_primary_10_1111_j_1423_0410_2010_01333_x crossref_primary_10_1007_s11239_013_1001_1 crossref_primary_10_1080_09537100801990582 crossref_primary_10_1080_03630260802625709 crossref_primary_10_3109_09537104_2014_983891 crossref_primary_10_1016_j_cca_2019_02_026 crossref_primary_10_1093_noajnl_vdac172 crossref_primary_10_1182_asheducation_2008_1_177 crossref_primary_10_1586_epr_10_88 crossref_primary_10_1056_NEJMra0804411 crossref_primary_10_1164_rccm_200807_1085OC crossref_primary_10_1182_blood_2019003976 crossref_primary_10_3390_ijms21249585 crossref_primary_10_1152_physiolgenomics_00130_2011 crossref_primary_10_1161_ATVBAHA_119_313280 crossref_primary_10_3389_fcvm_2018_00029 crossref_primary_10_1016_j_ancard_2014_08_008 crossref_primary_10_1213_ANE_0000000000001378 crossref_primary_10_1371_journal_pone_0060932 crossref_primary_10_1002_ajh_21057 crossref_primary_10_1186_1755_8794_5_28 crossref_primary_10_1016_j_bcmd_2009_12_003 crossref_primary_10_1016_j_ccell_2016_01_004 crossref_primary_10_1111_ejh_12879 crossref_primary_10_1016_j_freeradbiomed_2008_01_008 crossref_primary_10_1016_j_thromres_2011_02_012 crossref_primary_10_3390_ijms23063100 crossref_primary_10_1016_j_celrep_2020_107615 crossref_primary_10_1016_j_xcrm_2021_100425 crossref_primary_10_1016_S0027_9684_15_30807_5 crossref_primary_10_1146_annurev_physiol_030212_183752 crossref_primary_10_1371_journal_pone_0091315 crossref_primary_10_4049_jimmunol_1500259 crossref_primary_10_1182_blood_2014_04_512756 crossref_primary_10_1111_j_1600_0838_2009_00970_x crossref_primary_10_1038_nprot_2018_011 crossref_primary_10_1182_blood_2011_03_339705 crossref_primary_10_1053_j_seminhematol_2016_04_002 crossref_primary_10_1182_bloodadvances_2016000067 crossref_primary_10_3233_CH_189008 crossref_primary_10_3892_ol_2024_14725 crossref_primary_10_1016_j_thromres_2019_05_008 crossref_primary_10_1007_s11239_012_0864_x crossref_primary_10_1182_blood_2016_11_752279 crossref_primary_10_1093_eurheartj_ehw567 crossref_primary_10_1016_j_jaci_2016_01_032 crossref_primary_10_1371_journal_pone_0199461 crossref_primary_10_1097_MOH_0b013e328357010e crossref_primary_10_1111_trf_13896 crossref_primary_10_1016_j_niox_2022_09_002 crossref_primary_10_1002_ajh_22177 crossref_primary_10_1080_09537104_2019_1572876 crossref_primary_10_1111_j_1538_7836_2009_03700_x crossref_primary_10_1093_jn_137_6_1602S crossref_primary_10_1111_jth_13720 crossref_primary_10_1016_j_atherosclerosis_2020_05_022 crossref_primary_10_3389_fphys_2015_00065 crossref_primary_10_1002_ijc_33991 crossref_primary_10_1152_physiolgenomics_00009_2019 crossref_primary_10_1016_j_freeradbiomed_2020_02_033 crossref_primary_10_1038_s41598_019_56047_0 crossref_primary_10_1002_mas_20345 crossref_primary_10_1007_s00439_016_1642_1 crossref_primary_10_1016_j_thromres_2017_09_027 |
| Cites_doi | 10.1055/s-0038-1661310 10.1016/S0006-8993(02)02447-2 10.1016/j.it.2004.07.003 10.1182/blood-2003-05-1429 10.1001/jama.294.1.81 10.1186/gb-2003-4-9-r60 10.1172/JCI17912 10.1152/ajplung.00326.2005 10.1096/fj.04-2317fje 10.1182/blood-2002-03-0948 10.1042/bj3360001 10.1161/circulationaha.105.607333 10.1056/NEJMp038250 10.1056/NEJM199709113371107 10.1182/blood-2003-08-2760 10.1016/j.amjmed.2004.03.034 10.1056/NEJMoa035477 10.1001/jama.293.13.1653 10.1182/blood-2002-09-2797 10.1042/bj20031327 10.1055/s-0037-1615705 10.1172/JCI18908 10.1046/j.1365-2141.1998.00627.x 10.1016/0306-9877(95)90228-7 10.1097/00001721-199104000-00018 10.1046/j.1365-2141.2000.02353.x 10.1073/pnas.0506580102 10.1093/carcin/22.9.1521 10.1152/ajpendo.2001.280.1.E75 10.1074/mcp.M300063-MCP200 10.1097/00062752-200303000-00001 10.1038/sj.emboj.7600473 10.1016/j.thromres.2005.05.010 10.1074/jbc.R500031200 10.5858/2001-125-0072-DTTCLA 10.1152/ajpcell.1998.275.3.C740 10.1161/res.88.8.756 10.1160/TH05-02-0121 10.1111/j.1365-2141.2006.06110.x 10.1055/s-2004-833482 |
| ContentType | Journal Article |
| Copyright | 2007 INIST-CNRS |
| Copyright_xml | – notice: 2007 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1161/CIRCULATIONAHA.106.658641 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1524-4539 |
| EndPage | 1562 |
| ExternalDocumentID | PMC2225987 17353439 18642324 10_1161_CIRCULATIONAHA_106_658641 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R01 GM57384 – fundername: Intramural NIH HHS grantid: Z01 CL008050 – fundername: Intramural NIH HHS grantid: ZIA HL006013 – fundername: NIGMS NIH HHS grantid: R01 GM057384 |
| GroupedDBID | --- .-D .3C .55 .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAEJM AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AARTV AASOK AAUEB AAWTL AAXQO AAYOK AAYXX ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABXVJ ABZAD ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACOAL ACRKK ACWDW ACWRI ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFCHL AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJZMW ALKUP ALMA_UNASSIGNED_HOLDINGS AMJPA AMNEI ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C1A C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GX1 H0~ H13 HZ~ H~9 IKREB IKYAY IN~ J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B M18 N9A NEJ N~7 N~B O9- OAG OAH OBH OCB OCUKA ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RLZ S4R S4S T8P TEORI TR2 UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ZZMQN ~H1 .GJ 1CY 41~ AAQKA AASCR AASXQ ABASU ABVCZ ABXYN ABZZY ACLDA ACXJB ADFPA AEBDS AFBFQ AFMBP AFSOK AHQVU AKCTQ AKULP ALMTX AMKUR AOHHW AOQMC BS7 EEVPB EJD ERAAH FEDTE GNXGY GQDEL HLJTE HVGLF IPNFZ IQODW MVM N4W N~M ODA OHT P-K R58 RIG TSPGW WHG YQJ YXB YYP ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c494t-161590c24f88b723e713d6fa2b95f186ea4d36ff65a19386d7ca2f6c1391c1d93 |
| ISSN | 0009-7322 1524-4539 |
| IngestDate | Thu Aug 21 18:12:13 EDT 2025 Thu Jul 10 22:47:29 EDT 2025 Fri May 30 10:49:36 EDT 2025 Mon Jul 21 09:13:17 EDT 2025 Thu Apr 24 22:52:37 EDT 2025 Tue Jul 01 02:05:17 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | Human Hemoglobinopathy Sickle cell anemia genes Cardiovascular disease enzymes Hemopathy Metabolic pathway Metabolism platelets Genetic disease Polymerase chain reaction Signal transduction Platelet Hemolytic anemia Arginine Aminoacid thrombolysis |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c494t-161590c24f88b723e713d6fa2b95f186ea4d36ff65a19386d7ca2f6c1391c1d93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.106.658641 |
| PMID | 17353439 |
| PQID | 70304296 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2225987 proquest_miscellaneous_70304296 pubmed_primary_17353439 pascalfrancis_primary_18642324 crossref_primary_10_1161_CIRCULATIONAHA_106_658641 crossref_citationtrail_10_1161_CIRCULATIONAHA_106_658641 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2007-03-27 |
| PublicationDateYYYYMMDD | 2007-03-27 |
| PublicationDate_xml | – month: 03 year: 2007 text: 2007-03-27 day: 27 |
| PublicationDecade | 2000 |
| PublicationPlace | Hagerstown, MD |
| PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
| PublicationTitle | Circulation (New York, N.Y.) |
| PublicationTitleAlternate | Circulation |
| PublicationYear | 2007 |
| Publisher | Lippincott Williams & Wilkins |
| Publisher_xml | – name: Lippincott Williams & Wilkins |
| References | e_1_3_2_26_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_24_2 (e_1_3_2_44_2) 1997; 43 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 (e_1_3_2_13_2) 1982; 8 (e_1_3_2_19_2) 2004; 18 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 (e_1_3_2_10_2) 2003; 14 (e_1_3_2_27_2) 2006; 15 |
| References_xml | – ident: e_1_3_2_43_2 doi: 10.1055/s-0038-1661310 – volume: 18 start-page: 172 year: 2004 ident: e_1_3_2_19_2 publication-title: J Biol Regul Homeost Agents – ident: e_1_3_2_26_2 doi: 10.1016/S0006-8993(02)02447-2 – ident: e_1_3_2_36_2 doi: 10.1016/j.it.2004.07.003 – ident: e_1_3_2_37_2 doi: 10.1182/blood-2003-05-1429 – ident: e_1_3_2_2_2 doi: 10.1001/jama.294.1.81 – ident: e_1_3_2_23_2 doi: 10.1186/gb-2003-4-9-r60 – ident: e_1_3_2_40_2 doi: 10.1172/JCI17912 – ident: e_1_3_2_34_2 doi: 10.1152/ajplung.00326.2005 – ident: e_1_3_2_31_2 doi: 10.1096/fj.04-2317fje – ident: e_1_3_2_4_2 doi: 10.1182/blood-2002-03-0948 – ident: e_1_3_2_33_2 doi: 10.1042/bj3360001 – ident: e_1_3_2_38_2 doi: 10.1161/circulationaha.105.607333 – volume: 8 start-page: 163 year: 1982 ident: e_1_3_2_13_2 publication-title: Blood Cells – volume: 15 start-page: 148 year: 2006 ident: e_1_3_2_27_2 publication-title: Niger J Med – ident: e_1_3_2_7_2 doi: 10.1056/NEJMp038250 – ident: e_1_3_2_1_2 doi: 10.1056/NEJM199709113371107 – ident: e_1_3_2_20_2 doi: 10.1182/blood-2003-08-2760 – ident: e_1_3_2_9_2 doi: 10.1016/j.amjmed.2004.03.034 – ident: e_1_3_2_5_2 doi: 10.1056/NEJMoa035477 – ident: e_1_3_2_6_2 doi: 10.1001/jama.293.13.1653 – ident: e_1_3_2_17_2 doi: 10.1182/blood-2002-09-2797 – volume: 43 start-page: 311 year: 1997 ident: e_1_3_2_44_2 publication-title: Biochem Mol Biol Int – ident: e_1_3_2_35_2 doi: 10.1042/bj20031327 – ident: e_1_3_2_14_2 doi: 10.1055/s-0037-1615705 – ident: e_1_3_2_39_2 doi: 10.1172/JCI18908 – ident: e_1_3_2_29_2 doi: 10.1046/j.1365-2141.1998.00627.x – ident: e_1_3_2_21_2 doi: 10.1016/0306-9877(95)90228-7 – ident: e_1_3_2_11_2 doi: 10.1097/00001721-199104000-00018 – ident: e_1_3_2_28_2 doi: 10.1046/j.1365-2141.2000.02353.x – ident: e_1_3_2_22_2 doi: 10.1073/pnas.0506580102 – ident: e_1_3_2_24_2 doi: 10.1093/carcin/22.9.1521 – ident: e_1_3_2_30_2 doi: 10.1152/ajpendo.2001.280.1.E75 – ident: e_1_3_2_18_2 doi: 10.1074/mcp.M300063-MCP200 – ident: e_1_3_2_3_2 doi: 10.1097/00062752-200303000-00001 – ident: e_1_3_2_45_2 doi: 10.1038/sj.emboj.7600473 – ident: e_1_3_2_12_2 doi: 10.1016/j.thromres.2005.05.010 – ident: e_1_3_2_41_2 doi: 10.1074/jbc.R500031200 – ident: e_1_3_2_15_2 doi: 10.5858/2001-125-0072-DTTCLA – ident: e_1_3_2_25_2 doi: 10.1152/ajpcell.1998.275.3.C740 – volume: 14 start-page: 255 year: 2003 ident: e_1_3_2_10_2 publication-title: Blood Coagul Fibrinolysis – ident: e_1_3_2_32_2 doi: 10.1161/res.88.8.756 – ident: e_1_3_2_42_2 doi: 10.1160/TH05-02-0121 – ident: e_1_3_2_8_2 doi: 10.1111/j.1365-2141.2006.06110.x – ident: e_1_3_2_16_2 doi: 10.1055/s-2004-833482 |
| SSID | ssj0006375 |
| Score | 2.2549708 |
| Snippet | Background—
In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by... In sickle cell disease, ischemia-reperfusion injury and intravascular hemolysis produce endothelial dysfunction and vasculopathy characterized by reduced... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1551 |
| SubjectTerms | Adult Anemia, Sickle Cell - blood Arginase - blood Arginine - blood Biological and medical sciences Black People - genetics Blood and lymphatic vessels Blood Platelets - metabolism Blood vessels and receptors Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Fundamental and applied biological sciences. Psychology Gene Expression Profiling Humans Male Medical sciences Middle Aged Models, Biological Nitric Oxide - metabolism Nucleic Acid Amplification Techniques Oligonucleotide Array Sequence Analysis Polyamines - blood Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Transcription, Genetic Vertebrates: cardiovascular system |
| Title | Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/17353439 https://www.proquest.com/docview/70304296 https://pubmed.ncbi.nlm.nih.gov/PMC2225987 |
| Volume | 115 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkCYkhGDjUi7DSIiXKV1zqZM8RhWsRWsndQvqW-U4NkSUdOpaYPwG_iD_hnPiOGmmIgYvUeXETdrz-Vyc75xDyGsFLnAKnoEVKEdaaLFAD6rAcnmXJV2eeImHucOjMRvE3vtpb9pq_dpgLa1XSUf82JpX8j9ShTGQK2bJ_oNkqy-FAfgM8oUjSBiON5JxhHRwhU6k_F4SWgvGlcrmhsw8B18SRIOtIHKtIRZfsFPKV4l1k3Xab0GJ5cuP2CtCYk9pAAbWvsZuxd_4lWaa6_qrZTIciPbzXB7irn_jFY8peZAtRdkWbFu3n43dh0l0PIg-RP1BNBlqZY-ZmubsdBifDA-ncYWKeHx2Oq5oxfUrrdHpZDIsSIhnWZqDmhs1djN8pHPp4gB6N2NLVYpiNyObI2WooclDy3edpibXmaEGss6GYkbPcMPIQ9TqbDcgDA1Ifzjpxye6HPEg6kDY3AFPjXl2bTUNU-CaMa0ojjZcjt7qLXLbgQgGm2scT2v2EXP9nmnyhz9jl7wqb3_0x5s3XKe7F_wSVrHS7Ve2xUfXab4bftP5fXKvDHhopNH7gLRkvkf2o5wDEK_oG1pQkIt3O3tkd1QyPfbJzwrbtMY2rbBNF4oabNMGtmmJbVpim2Y5NdimFbapwTaeNtimiG2qsU0R27TE9kMSv3t73h9YZecQS3iht7IwjAm7wvFUECS-40rfdlOmuJOEPQWSkdxLXaYU63EIYAKW-oI7igkIh2xhp6H7iOzki1w-ITT1pSvAaCVcKk8wHnCZgNfscdEVXqpYmwRGKDNRltXH7i7zWRFeM3vWlCcMs5mWZ5s41dQLXVvmJpMOGpKvZ5aAa5OXBgozMBX4b_FcLtaXMzTu4H7CIz_WwKjn-m7PhdCkTfwGZKoLsAh980yefSqK0eN-URj4T__2WM_InXq9Pyc7q-VavgB_fpUcFCvjN-4m-iI |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amplified+expression+profiling+of+platelet+transcriptome+reveals+changes+in+arginine+metabolic+pathways+in+patients+with+sickle+cell+disease&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=RAGHAVACHARI%2C+Nalini&rft.au=XIULI+XU&rft.au=MUNSON%2C+Peter+J&rft.au=MORRIS%2C+Sidney+M&rft.date=2007-03-27&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0009-7322&rft.volume=115&rft.issue=12&rft.spage=1551&rft.epage=1562&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.106.658641&rft.externalDBID=n%2Fa&rft.externalDocID=18642324 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |